product
An interview with Lonza’s Minh Hong
Caroline Richards from European Pharmaceutical Review interviews Lonza's Minh Hong to find out more about the L7.
List view / Grid view
Stem Cells
article
Stem cell nano drug delivery applications to treat diabetes
Stem cell therapy is currently utilised in medicine for its application in tissue repair and regenerative medicine. Unique characteristics of stem cells, such as self-renewal and differentiation, allow its function to be applicable for therapeutic purposes. Nanotechnology and cell microencapsulation have been researched and used as a means to protect…
news
First patient treated in trial of ReNeuron’s retinitis pigmentosa cell therapy
ReNeuron has demonstrated that its Human Retinal Progenitor Cells (hRPCs) improve visual acuity in preclinical models of retinal degeneration...
news
MS treatment, AHSCT, shows “remarkable” results
18 January 2016 | By Victoria White
Autologous haematopoietic stem cell transplantation (AHSCT), developed at Sheffield Teaching Hospitals, has shown 'remarkable' results in patients with MS...
news
Stem cell therapy does not provide significant improvement in Crohn’s disease
17 December 2015 | By Victoria White
A clinical trial to test the effectiveness of a stem cell therapy among adults with difficult to treat Crohn's disease has found it is not significantly better than conventional treatment in producing sustained disease remission after one year...
news
Data from four trials support the safety and tolerability of hESC-derived retinal pigment epithelium
25 June 2015 | By
Results of four trials provide additional evidence supporting the safety and tolerability of hESC-derived retinal pigment epithelium...
news
Trial of new stem cell therapy for dystrophic epidermolysis bullosa (RDEB) gives promising results
1 June 2015 | By
Results from a trial of a new stem-cell based therapy for a rare skin condition, recessive dystrophic epidermolysis bullosa (RDEB), have been published...
article
Issue #2 2015 – Digital edition
In Issue #2 2015: Outsourcing, Drug pricing reforms, Stem Cells in-depth focus, Microbiology series, Environmental monitoring, LC-MS in-depth focus, Manufacturing solutions, PAT series and much more...
article
Stem Cells In-Depth Focus 2015
In this free-to-view Stem Cells In-Depth Focus, you can find out how computational ('in silico') methods can help to rationally choose bioactive small molecules to improve stem cell differentiation. The differentiation of pluripotent stem cells to hepatocyte-like cells is the focus of a second interesting article...
news
Ocata Therapeutics licenses induced pluripotent stem cell (iPSC) technology from Allele Biotechnology
24 March 2015 | By Victoria White
Ocata has announced that it has entered into a definitive agreement with Allele to access Allele’s proprietary technology for generating human iPSCs...
news
Promethera Biosciences receives approval in Belgium to enroll patients in the imminent HEP002 Phase IIb/III clinical trial
15 October 2014 | By Promethera Biosciences
HEP002 trial represents the world’s first Phase IIb/III trial with a stem cell-based medicinal product for the treatment of urea cycle disorders patients...
news
From stem cells to billions of human insulin-producing cells
10 October 2014 | By The Harvard Stem Cell Institute
Giant step toward new diabetes treatment...
news
New study shows UK public are largely unaware of stem cells as the potential uses are still being realised
9 October 2014 | By On Broadcast
18 years since the first cord blood transplants were performed in the UK, public knowledge on this life-saving process is still sorely lacking. A study of over 4,000 people found that nearly a third (32%) of Britons did not know you can store umbilical cord blood and tissue, while the…
product
Lonza interviewed at the ISSCR Annual Meeting 2014
Freddy White speaks with Don Paul Kovarcik, Business Development Manager, Lonza at the ISSCR Annual Meeting.
news
Stem cells: from bench to drug development
Working in stem cell research can be both immensely rewarding and notoriously challenging. One of the most prominent challenges is taking what are often exciting new advances in stem cell biology made in the research lab, and translating these into viable, impactful therapies for patients.
